Filter By

PRESS CONTACT

Anna Irwin, Director of Communications
301.215.8861 | irwina@hhmi.org

Press Release - 03/21/2017

New Movie THE LUCKY SPECIALS Delivers a Sensational, Musical Journey with a Powerful Public Health Message about Tuberculosis in Advance of World TB Day

SILVER SPRING, MD; MARCH 21, 2017 – THE LUCKY SPECIALS is a feature-length film slated to entertain millions in southern Africa and around the world with its dynamic storyline, new brand of African music, and unique look at the global epidemic of tuberculosis (TB). A private screening of the film was hosted by Discovery Learning Alliance and HHMI Tangled Bank Studios on March 21 at the AFI Silver Theatre and Cultural Center just outside of Washington, D.C.

Press Release - 10/10/2016

Smithsonian Presents Screening of Documentary Spillover: Zika, Ebola & Beyond

WASHINGTON, DC; NOVEMBER 10, 2016 – The Smithsonian’s National Museum of Natural History will host a free screening of the new HHMI’s Tangled Bank Studios film, Spillover: Zika, Ebola & Beyond, Nov. 15 at 6:30 p.m. in Baird Auditorium. A discussion hosted by BBC correspondent and television presenter Jane O’Brien will follow.

Press Release - 07/11/2016

SPILLOVER-ZIKA, EBOLA & BEYOND: DOCUMENTARY INVESTIGATES THE RISE AND SPREAD OF VIRUSES WORLDWIDE AND HOW TO STOP THE NEXT PANDEMIC

Arlington, VA; July 11, 2016 — Around the globe, viruses are on the march: Zika, Ebola, Nipah, Chikungunya, Dengue and West Nile. All of these viruses reside in animals and have the potential to “spillover” and infect humans. What’s behind the rise in spillover viruses? Are the United States and the world prepared to anticipate, contain and prevent the next outbreak?

Press Release - 04/13/2016

NOVA: CAN ALZHEIMER's BE STOPPED?

[BOSTON] – Alzheimer’s disease robs victims of their memories, their independence, and eventually their lives. It is the most common type of dementia, affecting five million people in the US alone, a number expected to double over the next 20 years as the population ages. With so much at stake, researchers, doctors, and patients worldwide are in a race to develop new drugs that could stop one of the most pressing global health challenges of our time.